The "Newborn Screening" Mandate: How 2026 is Reaching the Global South.
As we move through 2026, the industry is undergoing a "Geographic Expansion." This year, the Phenylketonuria Treatment Market has reached a "Screening Milestone," as countries like China and India implement national mandates for Tandem Mass Spectrometry (MS/MS) in newborn tests. This is proving essential for the 2026 "Early Detection" goal, as it identifies thousands of classic and variant PKU...
0 ความคิดเห็น 0 แชร์ 418 ยอดวิว 0 รีวิว